These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 661730

  • 1. [The effect of benzbromarone on fasting-hyperuricemia as a model (author's transl)].
    Schräpler P, Kleinschmidt A, Haese E.
    Med Klin; 1978 Jun 09; 73(23):861-6. PubMed ID: 661730
    [Abstract] [Full Text] [Related]

  • 2. [The uricosuric effect of benzbromaron and probenecid under fasting conditions (author's transl)].
    Schulz E, Schräpler P, Kleinschmidt A.
    Med Klin; 1978 Feb 17; 73(7):240-6. PubMed ID: 628361
    [Abstract] [Full Text] [Related]

  • 3. The pharmacology of hypouricemic effect of benzbromarone.
    Sinclair DS, Fox IH.
    J Rheumatol; 1975 Dec 17; 2(4):437-45. PubMed ID: 1206675
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R, Bresnik W, Müller MM.
    Fortschr Med; 1979 Nov 22; 97(44):2057-61. PubMed ID: 511087
    [Abstract] [Full Text] [Related]

  • 7. [Hypouricemic effect of benzbromarone especially in kidney failure].
    Didier M, Olmer M.
    Sem Hop; 1978 Apr 22; 54(9-12):463-5. PubMed ID: 210519
    [No Abstract] [Full Text] [Related]

  • 8. [Action of benzbromarone on the renal excretion of allantoin in normouricemic and hyperuricemic humans (author's transl)].
    Janzen D, Mertz DP, Scheiffele E, Kühnhold O.
    Klin Wochenschr; 1977 Nov 01; 55(21):1071-3. PubMed ID: 926719
    [Abstract] [Full Text] [Related]

  • 9. Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia.
    Heel RC, Brogden RN, Speight TM, Avery GS.
    Drugs; 1977 Nov 01; 14(5):349-66. PubMed ID: 338280
    [Abstract] [Full Text] [Related]

  • 10. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
    Mertz DP.
    Med Klin; 1977 Apr 15; 72(15):664-8. PubMed ID: 857138
    [Abstract] [Full Text] [Related]

  • 11. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
    Mertz DP.
    MMW Munch Med Wochenschr; 1978 Oct 20; 120(42):1387-90. PubMed ID: 101792
    [Abstract] [Full Text] [Related]

  • 12. [Normurat (benzbromaron) in the treatment of gout].
    Bosmanský K, Trnavský K.
    Z Rheumatol; 1979 Oct 20; 38(9-10):342-8. PubMed ID: 525067
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic and clinical studies of a new uricosuric agent - benzbromarone.
    Yu TF.
    J Rheumatol; 1976 Sep 20; 3(3):305-12. PubMed ID: 978666
    [Abstract] [Full Text] [Related]

  • 14. Effect of probenecid and benzbromarone on gluconeogenesis in isolated rat liver cells.
    Rodilla F, Sánchez-Beltrán MJ, Izquierdo R, Gómez-Ruiz MD, Cabo J.
    Rev Esp Fisiol; 1989 Dec 20; 45(4):391-4. PubMed ID: 2631163
    [Abstract] [Full Text] [Related]

  • 15. [Mechanism of fasting hyperuricemia].
    Asch L, Asch G.
    Rev Rhum Mal Osteoartic; 1980 Nov 20; 47(11):631-4. PubMed ID: 7444305
    [Abstract] [Full Text] [Related]

  • 16. Renal handling of uric acid in man.
    Levinson DJ, Decker DE, Sorensen LB.
    Ann Clin Lab Sci; 1982 Nov 20; 12(1):73-7. PubMed ID: 7065639
    [Abstract] [Full Text] [Related]

  • 17. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
    Matzkies F, Neuwirth R, Berg G.
    Fortschr Med; 1976 Sep 16; 94(26):1427-9. PubMed ID: 976920
    [Abstract] [Full Text] [Related]

  • 18. [The effect of benzbromarone and its combination with hydrochlorothiazide on the renal excretion of uric acid and electrolytes].
    Malý J.
    Cas Lek Cesk; 1986 Aug 22; 125(34):1053-6. PubMed ID: 3756994
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of benzbromarone in 100mg and 50mg doses on healthy subjects].
    Matzkies F, Berg G.
    Fortschr Med; 1977 Jul 21; 95(27):1745-7. PubMed ID: 903059
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.